There are 2789 resources available
1350P - Characteristics, treatment patterns and outcome of non-small cell lung cancer (NSCLC) patients presenting with brain-only metastatic disease
Presenter: Amir Sabouhanian
Session: ePoster Display
1352P - A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
Presenter: Giulia Mazzaschi
Session: ePoster Display
1353P - Similarities and differences in the spatial distribution of brain metastases in small cell lung cancer and non-small cell lung cancer: Quantitative analysis and identifying metastatic risk region may be helpful for the whole-brain radiotherapy with non-uniform dose prescriptions
Presenter: Rongjie Tao
Session: ePoster Display
Resources:
Abstract
1308P - Efficacy and safety of anti-PD-1 therapy plus anlotinib in previously treated advanced NSCLC
Presenter: Xin Lv
Session: ePoster Display
1309P - A multicenter phase I study of radium-223 (Ra-223) plus pembrolizumab in patients with stage IV non-small cell lung cancer (NSCLC)
Presenter: Martin Reck
Session: ePoster Display
1310P - Toripalimab combined with chemotherapy as second-line treatment of advanced non-small cell lung cancer (NSCLC): A single center retrospective study
Presenter: man Jiang
Session: ePoster Display
1311P - The role of inflammatory biomarkers in advanced non-small cell lung cancer patients treated with chemo-immunotherapy
Presenter: Emma Zattarin
Session: ePoster Display
1312P - Prognostic impact of KRAS status in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitor monotherapy
Presenter: Giacomo Pelizzari
Session: ePoster Display
1314P - Preliminary results of sequential combination of immunotherapy followed by chemotherapy in advanced non-small cell lung cancer
Presenter: Luc Heraudet
Session: ePoster Display